AIP Stock Overview
Adcock Ingram Holdings Limited manufactures, markets, and distributes healthcare products in South Africa, the United States, Canada, the United Kingdom, rest of Europe, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
My Notes
NewNotes are coming soon
Adcock Ingram Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R51.49 |
| 52 Week High | R58.27 |
| 52 Week Low | R44.11 |
| Beta | 0.35 |
| 1 Month Change | 1.96% |
| 3 Month Change | 7.97% |
| 1 Year Change | 0.078% |
| 3 Year Change | 1.26% |
| 5 Year Change | -21.94% |
| Change since IPO | 51.22% |
Recent News & Updates
Shareholder Returns
| AIP | ZA Pharmaceuticals | ZA Market | |
|---|---|---|---|
| 7D | 3.0% | 3.5% | 1.2% |
| 1Y | 0.08% | -19.6% | 1.5% |
Return vs Industry: AIP exceeded the ZA Pharmaceuticals industry which returned -19.6% over the past year.
Return vs Market: AIP underperformed the ZA Market which returned 1.5% over the past year.
Price Volatility
| AIP volatility | |
|---|---|
| AIP Average Weekly Movement | 4.1% |
| Pharmaceuticals Industry Average Movement | 4.6% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in ZA Market | 12.2% |
| 10% least volatile stocks in ZA Market | 2.9% |
Stable Share Price: AIP is not significantly more volatile than the rest of ZA stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: AIP's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1890 | n/a | Andy Hall | https://www.adcock.co.za |
Adcock Ingram Holdings Limited manufactures, markets, and distributes healthcare products in South Africa, the United States, Canada, the United Kingdom, rest of Europe, and internationally. It offers a portfolio of over-the-counter products, prescription medicines, and consumer products, as well as instrumentation and surgical products. The company also provides a range of pharmaceutical products, such as women’s health, cannabidiol oil, antiretroviral, dermatology, central nervous system, respiratory, ophthalmology, generics, cardiovascular, pain, gastroenterology, energy supplements, colds and flu, personal care, feminine hygiene, digestive well-being, allergies, baby care, cough, food and nutrition supplements, vitamins, and minerals supplements.
Adcock Ingram Holdings Limited Fundamentals Summary
| AIP fundamental statistics | |
|---|---|
| Market Cap | R8.33b |
| Earnings (TTM) | R800.35m |
| Revenue (TTM) | R8.71b |
10.4x
P/E Ratio1.0x
P/S RatioIs AIP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AIP income statement (TTM) | |
|---|---|
| Revenue | R8.71b |
| Cost of Revenue | R5.68b |
| Gross Profit | R3.03b |
| Other Expenses | R2.23b |
| Earnings | R800.35m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.95 |
| Gross Margin | 34.78% |
| Net Profit Margin | 9.19% |
| Debt/Equity Ratio | 0% |
How did AIP perform over the long term?
See historical performance and comparison